Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · Real-Time Price · USD
0.5150
-0.0349 (-6.35%)
At close: Apr 1, 2025, 4:00 PM
0.5580
+0.0429 (8.34%)
After-hours: Apr 1, 2025, 4:38 PM EDT

Indaptus Therapeutics Stock Forecast

INDP's stock price has decreased by -76.29% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Indaptus Therapeutics stock have an average target of 8.50, with a low estimate of 5.00 and a high estimate of 12. The average target predicts an increase of 1,550.49% from the current stock price of 0.52.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $5.00 $8.50 $12 $12
Change +870.87% +1550.5% +2230.1% +2230.1%
* Price targets were last updated on Nov 13, 2024.

Analyst Ratings

The average analyst rating for Indaptus Therapeutics stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Oct '24Nov '24Dec '24Jan '25Feb '25Mar '25
Strong Buy 122222
Buy 000000
Hold 000000
Sell 000000
Strong Sell 000000
Total 122222

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Maxim Group
Maxim Group
Strong Buy
Maintains
$8$5
Strong Buy Maintains $8$5 +870.87% Nov 13, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$12
Strong Buy Reiterates $12 +2,230.10% Oct 16, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$12
Strong Buy Reiterates $12 +2,230.10% Jun 17, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$12
Strong Buy Reiterates $12 +2,230.10% Apr 15, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$12
Strong Buy Reiterates $12 +2,230.10% Sep 20, 2023
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
from 137.06M
Revenue Next Year
n/a
EPS This Year
-1.11
from -1.61
EPS Next Year
-0.64
from -1.11
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027 FY 2028 FY 2029
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027 Dec 31, 2028 Dec 31, 2029
Revenue
---48.32M137.06M
Revenue Growth
----183.65%---
EPS
-1.84-1.89-1.73-1.84-1.61-1.11-0.64-0.64
EPS Growth
--------
Forward PE
--------
No. Analysts -----433
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20252026202720282029
High n/a n/a n/a
Avg n/a n/a n/a
Low n/a n/a n/a

Revenue Growth

Revenue Growth 20252026202720282029
High - - -
Avg - - -
Low - - -

EPS Forecast

EPS 202520262027
High -0.83 -0.66 -0.66
Avg -1.11 -0.64 -0.64
Low -1.35 -0.62 -0.62

EPS Growth

EPS Growth 202520262027
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.